The US Food and Drug Administration (FDA) approved AstraZeneca’s cancer drugs Imfinzi and Imjudo in combination with chemotherapy to treat patients with stage 4 non-small cell lung cancer. This approval is based on the phase 3 data published in September 2021. Imfinzi and Imjudo with chemotherapy have shown an overall 23 percent improvement in patients […]
Continue Reading
The US Centers for Disease Control and Prevention (CDC) are investigating the cause of the listeria outbreak across six states in the United States. The US CDC has issued an advisory for the people who consume Deli meat, including lunch meats, cold cuts, and hot dogs. The older individuals above 65 years, pregnant women, and […]
Continue Reading
The US Food and Drug Administration’s (FDA) Pulmonary-Allergy Drugs Advisory Committee (PADAC) has recommended AstraZeneca’s PT027 for the treatment of asthma in people aged 18 years and older. The Committee has voted 9 to 8 for adolescents aged 12 to 17 years, and the data do not support a favourable risk assessment for the use […]
Continue Reading
The UK Medicines and Healthcare Products Regulatory Agency (MHRA), has approved Nuvaxovid, COVID-19 vaccine developed by Novavax, as a vaccine booster for 12 years to 17 years old children. The approval follows a review of the safety, effectiveness, and quality of the COVID-19 vaccine in the age group, and expert advice from the Commission on […]
Continue Reading
Using cutting-edge genome sequencing techniques, researchers at the Indian Institute of Technology (IIT), Jodhpur, have discovered variants in the COVID-19 virus’s RNA, according to officials. The fixation of these intra-host variations and mutations that results in variants have both been researched by experts. The journal “Nucleic Acid Research” has published the findings of the two-phase […]
Continue Reading
According to a new study, Moderna’s COVDI-19 vaccine, Spikevax, has a higher risk of heart inflammation associated with products from Pfizer and BioNTech. The study, published in the Journal of the American College of Cardiology, concluded that the risk of myocarditis is much higher after a second dose of Moderna’s Spikevax compared with Comirnaty from […]
Continue Reading
The US Food and Drug Administration (FDA) has approved Zydus Lifesciences’ hypertension drugs Bisoprolol Fumrate and Hydrochlorothiazide tablets in the United States. The US FDA has given clearance to Zydus Lifesciences to market generic medicines in the United States in multiple strengths. With increasing cases of hypertension, the combination of Bisoprolol Fumrate and hydrochlorothiazide is […]
Continue Reading
Due to low demand, about 50 million doses of Covaxin, a COVID-19 vaccine produced by Bharat Biotech, are expected to run out early in the following year. Despite having planned for production to achieve a yearly capacity of 1 billion doses by the end of 2021, Bharat Biotech, halted manufacturing the two-dose immunization Covaxin earlier […]
Continue Reading
The European Commission (EC) approved Beyfortus, jointly developed by AstraZeneca and Sanofi, for the prevention of a common and highly contagious type of respiratory infection in infants. This long-acting therapy, which is also known as nirsevimab, was given marketing authorisation in the European Union (EU) for the prevention of disease from several infections caused by […]
Continue Reading
Pfizer Inc.’s Paxlovid antiviral that lowers rates of illness and death in people infected with COVID-19 also reduces the risk of some symptoms of long-COVID, a study found. According to the study, taking Paxlovid within five days of testing positive for COVID-19 infection was linked to a 26 percent lower risk of post-viral complications. This […]
Continue Reading